LeMaitre Vascular, Inc. (LMAT) Sets 52-Week High on Apr, 16 at $40.96

April 16, 2018 - By Ira Colvard

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Corporate Logo

Big Money Sentiment decreased to 0.91 in 2017 Q4. It has change of 0.80, from 2017Q3’s 1.71. The ratio dropped due to LeMaitre Vascular, Inc. positioning: 24 sold and 44 reduced. 19 funds took positions and 43 increased positions. Investors holded 13.06 million in 2017Q3 but now own 13.74 million shares or 5.25% more.
First Light Asset Mngmt Limited owns 46,119 shs or 0.4% of their US capital. Strs Ohio holds 0% or 22,500 shs in its capital. The Minnesota-based Thrivent Fincl For Lutherans has invested 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Laurion Capital Mngmt L P stated it has 15,042 shs or 0% of all its holdings. 926,066 are owned by Vanguard Group Inc. Dupont Cap Mgmt Corp owns 0.01% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 13,319 shs. New York-based Blackrock has invested 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Parallax Volatility Advisers Lp invested in 2,268 shs or 0% of the stock. Bahl & Gaynor has 63,825 shs for 0.02% of their capital. Oppenheimer Asset Management holds 0.01% of its capital in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 6,313 shs. The North Carolina-based Bb&T has invested 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Morgan Stanley holds 0% or 101,139 shs. Texas Permanent School Fund reported 10,287 shs stake. Glenmede Trust Com Na accumulated 1,100 shs. Us Comml Bank De holds 0% or 4,373 shs in its capital.

LeMaitre Vascular, Inc. had 3 insider sales and 0 insider buys since February 26, 2018. This’s net activity of $4.81 million.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) hit $40.96 stock price also a yearly high. Barchart.com published it on Apr, 16. The company has $789.76M market cap. The valuation of NASDAQ:LMAT can change by $23.69 million if our $42.19 PT is hit.

On during the last trading session the stock increased $0.71 or 1.76%, reaching $40.96.Currently LeMaitre Vascular, Inc. is uptrending after 48.54% change in last April 16, 2017. LMAT has 51,687 shares volume. LMAT outperformed the S&P500 by 36.99%.

Analysts await LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report earnings on April, 25. They expect $0.20 EPS, up 25.00 % or $0.04 from last year’s $0.16 per share. LMAT’s profit will be $3.86M for 51.20 P/E if the $0.20 EPS becomes a reality. After $0.21 actual EPS reported by LeMaitre Vascular, Inc. for the previous quarter, Wall Street now forecasts -4.76 % negative EPS growth.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Ratings Coverage

Total analysts of 5 have positions in Lemaitre Vascular (NASDAQ:LMAT) as follows: 1 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 20%. The firm has $40.0 highest while $29 is the lowest [Target]. The average target $34.33 is -16.19% below the last ($40.96) price. Since October 27, 2017 according to StockzIntelligence Inc Lemaitre Vascular has 6 analyst reports. On Thursday, February 22 the firm has “Buy” rating by Stifel Nicolaus given. On Friday, October 27 the stock of LeMaitre Vascular, Inc. (NASDAQ:LMAT) earned “Hold” rating by First Analysis. On Friday, October 27 the stock has “Hold” rating by Canaccord Genuity. In Friday, October 27 report Benchmark downgraded the stock to “Hold” rating. On Friday, October 27 the rating was maintained by Stifel Nicolaus with “Buy”.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.The firm is worth $789.76 million. The firm offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature.47.63 is the P/E ratio. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.